🔎 Trials Near Me

Akèy › Maladi poumon › North Carolina › Durham

Etid klinik pou Maladi poumon nan Durham, NC

13 etid pou Maladi poumon ap chèche patisipan nan sit nan ak bò kote Durham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

Ap rekriteFaz 3
  • Research Site, Durham
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT05624450

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Ap rekriteFaz 3
  • Duke Cancer Center, Durham
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06765109

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

Ap rekriteFaz 3
  • Duke Vaccine and Trials Unit, Durham
  • Duke Vaccine and Trials Unit, Durham
  • Duke University - Main Hospital and Clinics, Durham
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07013474

American Lung Association (ALA) Lung Health Cohort

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Duke University, Durham
Laj 25 a 35 · Tout sèks · Mizajou Sep 23, 2026 · NCT04543461

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

Ap rekriteFaz 3
  • GSK Investigational Site, Durham
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06572384

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Ap rekriteFaz 3
  • Duke Cancer Institute, Durham
  • University of North Carolina Medical Center, Chapel Hill · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06119581

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age

Ap rekriteFaz 4Volontè an sante akeyi
  • Duke Vaccine and Trials Unit, Durham
Laj 18 a 64 · Tout sèks · Mizajou Aug 7, 2026 · NCT07730450

H01 in Adults With Interstitial Lung Disease (The SOLIS Study)

Ap rekriteFaz 2
  • NIEHS Clinical Research Unit (CRU), Research Triangle Park · 7 mi lwen
Laj 18 a 100 · Tout sèks · Mizajou Jul 28, 2026 · NCT06325696

Deep Functional Phenotyping of the ALA Lung Health Cohort

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Duke University, Durham
Laj 25 a 35 · Tout sèks · Mizajou Jul 17, 2026 · NCT06177717

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

Ap rekriteFaz 2
  • University of North Carolina, Chapel Hill · 10 mi lwen
Laj 18 a 70 · Tout sèks · Mizajou Jun 26, 2026 · NCT04614103

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Ap rekrite
  • Durham VA Medical Center, Durham, NC, Durham
Laj 18 ak plis · Tout sèks · Mizajou Feb 19, 2026 · NCT02984761

Hyperpolarized 129Xe MRI for Imaging Pulmonary Function

Ap rekriteFaz 2Volontè an sante akeyi
  • Duke University Medical Center, Durham
Laj 18 ak plis · Tout sèks · Mizajou Jan 16, 2026 · NCT01280994

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

Ap rekriteFaz 2
  • Duke University Hospital, Durham
Laj 18 ak plis · Tout sèks · Mizajou Dec 15, 2025 · NCT06619561

Etid Maladi poumon nan lòt vil

Lòt etid nan Durham

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.